GSK - Week In Review: Qiming Venture Closes $1.1 Billion Fund For Healthcare/TMT Investments
Deals and Financings
Qiming closed its seventh China-focused US dollar fund with $1.1 billion for early stage Healthcare and TMT investments. Currently, Qiming manages nine US dollar funds and five RMB funds with $5.3 billion of assets under management. Despite the COVID-19 pandemic, Qiming said it closed Fund VII on time and at its target. Two years ago, Qiming announced its sixth dollar denominated fund with $935 million and, simultaneously, its fifth RMB fund with the equivalent of $334 million. Qiming has China offices in Shanghai, Beijing, Hong Kong and Shenzhen.
Zai Lab (ZLAB) of